Semi-synthetic macrolide
anthelmintic consisting of oxime derivatives of Milbemycin A3 and A4
Market Overview
Effectively prevents and controls both internal parasites and external parasites
Used alone or in combinations with nitenpyram, lufenuron, spinosad, and praziquantel
Parasite control mechanism: blocks nerve signaling, paralyzes parasites, stops feeding, ultimately causing parasite death
Market Value & Growth Projections
Market Insights:
Global Market:
2023: USD 183.70 million
2032 (Projected): USD 321.06 million
CAGR: 6.40% (2024-2030)
North America:
2023: USD 53.26 million
CAGR: 5.49% (2025-2032)
Key Market Drivers:
Rising pet ownership globally
Increasing awareness about pet health and parasite prevention
Growing demand for effective antiparasitic medications
Expansion of veterinary healthcare infrastructure
Development of combination therapies for comprehensive parasite control
By Type
98% Purity
Purity Greater than 98%
Key Market Players
LINGYUN
Regional Market Analysis
North America:
Key Countries- USA, Canada, Mexico
Europe:
Key Countries- Germany, UK, France, Russia, Italy, Rest of Europe
Asia-Pacific:
Key Countries- China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific
South America:
Key Countries- Brazil, Argentina, Columbia, Rest of South America
Middle East and Africa:
Key Countries- Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA
